Smith & Nephew plc vs Vanguard Growth Index Fund ETF — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Vanguard Growth Index Fund ETF trades at $86.16. The key difference: Smith & Nephew plc pays a 2.57% dividend while Vanguard Growth Index Fund ETF pays none, and Vanguard Growth Index Fund ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | VUG | |
|---|---|---|
Market Cap | $12.64B | — |
Sector | Health | Sector/Thematic |
52-Week High | $38.70 | $90.29 |
52-Week Low | $28.73 | $70.00 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.57% | — |
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →